Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Which hypocholesteremic agents for which hypercholesterolemias?].

F Dairou1

  • 1Service d'Endocrinologie, Hôpital Pitié-Salpêtrière, Paris.

Annales De Cardiologie Et D'Angeiologie
|December 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Usefulness in predicting coronary artery disease by ultrasonic evaluation of the carotid arteries in asymptomatic hypercholesterolemic patients with positive exercise stress tests.

The American journal of cardiology·1999
Same author

[LDL-apheresis therapy, methods and indications].

Presse medicale (Paris, France : 1983)·1999
Same author

Lipid disorders and cardiovascular risks in nephrology.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1998
Same author

[Effects of rilmenidine (hyperium) on lipid balance in hyperlipidemic hypertensive patients. Randomized, controlled, double-blind 8-week study vs. captopril in parallel groups].

Annales de cardiologie et d'angeiologie·1996
Same author

Phenotypic expression in double heterozygotes for familial hypercholesterolemia and familial defective apolipoprotein B-100.

Human mutation·1996
Same author

[Metastatic pulmonary carcinoma, revealed by Cushing syndrome, initially considered to have a pituitary origin. Course over 25 years].

Presse medicale (Paris, France : 1983)·1995

This summary covers hypercholesterolemia treatments, including bile acid sequestrants, HMG-CoA reductase inhibitors, and fibrates. Lifestyle changes and addressing other risk factors are crucial before drug therapy.

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Metabolic Disorders

Context:

  • Hypercholesterolemia management requires a multi-faceted approach.
  • Understanding drug classes and their mechanisms is key.

Purpose:

  • To outline the primary drug classes used for hypercholesterolemia.
  • To detail the essential preliminary steps before initiating hypolipidemic drug therapy.

Summary:

  • Bile acid sequestrants and HMG-CoA reductase inhibitors increase LDL receptors.
  • Fibrates are second-line for hypercholesterolemia but primary for hypertriglyceridemia, increasing HDL.
  • Adjuvant agents include probucol, neomycin, and nicotinic acid.

Impact:

  • Highlights the importance of classifying the disorder, eliminating secondary causes, and family assessment.

Related Experiment Videos

  • Emphasizes the necessity of a permanent dietary phase and managing other atherogenic risk factors.
  • Stresses the avoidance of iatrogenic effects in hypolipidemic drug prescription.